Press releases

Date		Headline
27/01/10		Oxford BioMedica and ALS Therapy Development Institute Extend Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis
27/01/10		Oxford BioMedica and Bavarian Nordic Announce Settlement of MVA-BN^® Litigation and Cross License of Patents
22/01/10		Oxford BioMedica Secures Exclusive License for Key Intellectual Property Related to Ocular Products
20/01/10		Oxford BioMedicas UshStat For Usher Syndrome Receives European Orphan Drug Designation
05/01/10		Oxford BioMedica Plc Management and Board Changes